Partner Content Partner Content Superbugs: Exclusive Interviews Released with ABAC Therapeut... Q&A's Out Ahead of Superbugs 2018
Partner Content Partner Content Agenda released for SMi’s 20th Annual Superbugs European Sho... Agenda released for 20th Annual Superbugs Event
News Merck axes hepatitis C drug development Focus shifts to Keytruda amid competition from Gilead and shrinking market.
News Immunovant's thyroid eye disease drug flunks pivotal trials Immunovant shares were sliding today after it reported that FcRn blocker batoclimab failed a pair of phase 3 trials in thyroid eye disease.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
